Atlas Trials

Pilot Study of Nivolumab in Pediatric Patients With Hypermutant Cancers

Clinical trial NCT02992964 · TERMINATED

Trial details

NCT number
NCT02992964
Sponsor
The Hospital for Sick Children
Status
TERMINATED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Refractory or Recurrent Hypermutated MalignanciesBiallelic Mismatch Repair Deficiency (bMMRD) Positive Patients
Start date
2017-05-15
Primary completion
2023-11-20
Enrollment
11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.